OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS

Mergers & Acquisitions

M&A Transactions

M&A Transaction Chart

Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.

M&A Transactions Commentary

Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.

  • The Largest Closed M&A Deal of the Week:
  • On May 13, 2024, CV Sciences (CVSI: OTCQB), a consumer wellness company specializing in nutraceuticals and based on the company’s hemp extracts and other natural ingredients, closed its $1M purchase of Elevated Softgels. Elevated is a leading manufacturer of encapsulated soft gels and tinctures. CV Science plans to utilize Elevated to produce roughly 50% of its products, producing meaningful cost savings
  • The $1M transaction value was paid via $700K of CV Science stock, $100k of cash, and $200K of earnouts.